[Extracellular matrix proteins and glycoproteins in the cardiovascular system].
Sasamura
Hiroyuki
H
Department of Internal Medicine, School of Medicine, Keio University.
Saruta
Takao
T
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D058578:Biglycan; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D005109:Extracellular Matrix / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D016326:Extracellular Matrix Proteins / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D020782:Matrix Metalloproteinases / Q000502:physiology; D011509:Proteoglycans / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D012084:Renin-Angiotensin System / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000502:physiology
D000959:Antihypertensive Agents; C546884:BGN protein, human; D058578:Biglycan; D016326:Extracellular Matrix Proteins; D011509:Proteoglycans; D016212:Transforming Growth Factor beta; D020782:Matrix Metalloproteinases